Related Experiment Video
Updated: Jul 11, 2026

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis
Published on: December 30, 2025
Myelodysplastic syndrome and sagittal sinus thrombosis
P F Finelli1, R B Harrison, D F Uphoff
1Department of Neurology, Hartford Hospital, University of Connecticut School of Medicine, Hartford, CT, USA.
Abstract:
After a 5-day illness beginning with severe headache, a 46-year-old man with myelodysplastic syndrome died of complications from cerebral venous thrombosis. Considering the underlying hematologic abnormality, multiple therapies, and potential for leukemic transformation, we suggest that patients with myelodysplastic syndrome may be at increased risk for developing cerebral venous thrombosis.
Insights
Patients with myelodysplastic syndrome (MDS) may face a higher risk of cerebral venous thrombosis (CVT). This case highlights the potential link between MDS and CVT complications, warranting further investigation into this association.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Cerebral venous thrombosis (CVT) is a rare but serious condition affecting venous drainage in the brain.
- Patients with hematologic abnormalities may have altered thrombosis risk.
Purpose of the Study:
- To report a case of cerebral venous thrombosis in a patient with myelodysplastic syndrome.
- To explore the potential association between myelodysplastic syndrome and an increased risk of cerebral venous thrombosis.
Main Methods:
- Case report presentation.
- Review of patient's clinical history, hematologic status, and treatment course.
- Discussion of potential risk factors and pathogenetic mechanisms.
Main Results:
- A 46-year-old man with myelodysplastic syndrome developed severe headache and subsequently died from cerebral venous thrombosis complications.
- The patient had received multiple therapies for his underlying hematologic condition.
- Leukemic transformation was a potential concern in this patient.
Conclusions:
- Myelodysplastic syndrome may be an independent risk factor for cerebral venous thrombosis.
- The complex interplay of hematologic dyscrasia, therapies, and potential for malignant transformation in MDS patients warrants consideration for increased CVT risk.
- Further research is needed to elucidate the mechanisms and confirm the association between MDS and CVT.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Mitral Stenosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Hemorrhagic Stroke l: Introduction